Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA

Osteoporosis International

Volumn 21, Issue 8, 2010, Pages 1427-1436

  Asche, C ^a   Nelson, R ^b   McAdam Marx, C ^a   Jhaveri, M ^c   Ye, X ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c SANOFI   (France)

Author keywords

Bone mineral density; Fracture; Oral bisphosphonate; Osteoporosis; Real world data

Indexed keywords

ALENDRONIC ACID; CORTICOSTEROID; IBANDRONIC ACID; RISEDRONIC ACID;

ADULT; AGED; ARTICLE; BODY MASS; ELECTRONIC MEDICAL RECORD; FEMALE; FRAGILITY FRACTURE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POSTMENOPAUSE OSTEOPOROSIS; PREDICTOR VARIABLE; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SMOKING; UNITED STATES;

ADMINISTRATION, ORAL; AGE FACTORS; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; DRUG PRESCRIPTIONS; DRUG UTILIZATION; EPIDEMIOLOGIC METHODS; FEMALE; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES;

EID: 77954540740     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-009-1079-7     Document Type: Article

References (43)

1. NB Watts P Geusens IP Barton D Felsenberg 2005 Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD J Bone Miner Res 20 12 2097 2104 10.1359/JBMR.050814 16294263 (Pubitemid 41698773)
2. NOF Fast Facts. 2009; http://www.nof.org/osteoporosis/diseasefacts.htm. Accessed 3/17/2009
3. RS Braithwaite NF Col JB Wong 2003 Estimating hip fracture morbidity, mortality and costs J Am Geriatr Soc 51 3 364 370 10.1046/j.1532-5415.2003. 51110.x 12588580 (Pubitemid 36348898)
4. A Oleksik P Lips A Dawson, et al. 2000 Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures J Bone Miner Res 15 7 1384 1392 10.1359/jbmr.2000.15.7.1384 1:STN:280: DC%2BD3M%2FhtF2jtg%3D%3D 10893688
5. NF Ray JK Chan M Thamer LJ Melton 3rd 1997 Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation J Bone Miner Res 12 1 24 35 10.1359/jbmr.1997.12.1.24 1:STN:280:DyaK2szot1Oguw%3D%3D 9240722 (Pubitemid 27053608)
6. C McAdam-Marx J Lafleur C Kirkness C Asche 2007 Postmenopausal osteoporosis current and future treatment options P&T 32 7 392 402
7. SH Gehlbach M Fournier C Bigelow 2002 Recognition of osteoporosis by primary care physicians Am J Public Health 92 2 271 273 10.2105/AJPH.92.2.271 11818304
8. WHO (2003) Prevention and management of osteoporosis. Geneva
9. RM Brennan J Wactawski-Wende CJ Crespo J Dmochowski 2004 Factors associated with treatment initiation after osteoporosis screening Am J Epidemiol 160 5 475 483 10.1093/aje/kwh245 15321845 (Pubitemid 39166981)
10. RP Cole S Palushock A Haboubi 1999 Osteoporosis management: physicians' recommendations and womens' compliance following osteoporosis testing Women Health 29 1 101 115 10.1300/J013v29n01-08 1:STN:280:DyaK1Mzls1Kmsw%3D%3D 10427644 (Pubitemid 29363858)
11. A Cranney JF Tsang 2008 Leslie WD (2008) Factors predicting osteoporosis treatment initiation in a regionally based cohort Osteoporos Int 20 9 1621 1625 10.1007/s00198-008-0823-8 19096744
12. JK Kirk JG Spangler FS Celestino 2000 Prevalence of osteoporosis risk factors and treatment among women aged 50 years and older Pharmacotherapy 20 4 405 409 10.1592/phco.20.5.405.35051 1:STN:280:DC%2BD3c3jtlehtw%3D%3D 10772371
13. CD Marci WB Anderson MB Viechnicki SL Greenspan 2000 Bone mineral densitometry substantially influences health-related behaviors of postmenopausal women Calcif Tissue Int 66 2 113 118 10.1007/s002230010024 1:CAS:528: DC%2BD3cXpslKhsA%3D%3D 10652958 (Pubitemid 30056705)
14. G Phillipov E Mos S Scinto PJ Phillips 1997 Initiation of hormone replacement therapy after diagnosis of osteoporosis by bone densitometry Osteoporos Int 7 2 162 164 10.1007/BF01623693 1:CAS:528:DyaK2sXjvFegtrw%3D 9166398
15. BL Riggs LJ Melton 3rd 1995 The worldwide problem of osteoporosis: insights afforded by epidemiology Bone 17 5 Suppl 505S 511S 10.1016/8756- 3282(95)00258-4 1:STN:280:DyaK287ks12gtg%3D%3D 8573428
16. SM Rubin SR Cummings 1992 Results of bone densitometry affect women's decisions about taking measures to prevent fractures Ann Intern Med 116 12 Pt 1 990 995 1:STN:280:DyaK383msVKnug%3D%3D 1586110
17. ES Siris PD Miller E Barrett-Connor, et al. 2001 Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment JAMA 286 22 2815 2822 10.1001/jama.286.22.2815 1:STN:280:DC%2BD3MjgtVGmug%3D%3D 11735756
18. DH Solomon MA Brookhart TK Gandhi, et al. 2004 Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics Am J Med 117 12 919 924 10.1016/j.amjmed.2004.06.040 15629730 (Pubitemid 40075559)
19. DJ Torgerson RE Thomas MK Campbell DM Reid 1997 Randomized trial of osteoporosis screening. Use of hormone replacement therapy and quality-of-life results Arch Intern Med 157 18 2121 2125 10.1001/archinte.157.18.2121 1:STN:280:DyaK1c%2Fit1WjtA%3D%3D 9382669
20. RA Yood LR Harrold L Fish, et al. 2001 Prevention of glucocorticoid- induced osteoporosis: experience in a managed care setting Arch Intern Med 161 10 1322 1327 10.1001/archinte.161.10.1322 1:CAS:528:DC%2BD3MXktlers7Y%3D 11371261
21. KM Ryder RI Shorr FA Tylavsky, et al. 2006 Correlates of use of antifracture therapy in older women with low bone mineral density J Gen Intern Med 21 6 636 641 10.1111/j.1525-1497.2006.00468.x 16808749 (Pubitemid 43801495)
22. KB Freedman FS Kaplan WB Bilker BL Strom RA Lowe 2000 Treatment of osteoporosis: are physicians missing an opportunity? J Bone Joint Surg Am 82-A 8 1063 1070 1:STN:280:DC%2BD3cvjslarsQ%3D%3D 10954094
23. Nayak S, Roberts MS, Greenspan SL (2009) Factors associated with diagnosis and treatment of osteoporosis in older adults. Osteoporos Int (In Press)
24. S Epstein 2006 Update of current therapeutic options for the treatment of postmenopausal osteoporosis Clin Ther 28 2 151 173 10.1016/j.clinthera.2006.02. 007 1:CAS:528:DC%2BD28Xmtl2lsbk%3D 16678639
25. HD Nelson M Helfand SH Woolf JD Allan 2002 Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 137 6 529 541 12230356 (Pubitemid 35024625)
26. RA Deyo DC Cherkin MA Ciol 1992 Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 6 613 619 10.1016/0895-4356(92)90133-8 1:STN:280:DyaK38zgtVeqsA%3D%3D 1607900
27. C Simonelli YT Chen J Morancey AF Lewis TA Abbott 2003 Evaluation and management of osteoporosis following hospitalization for low-impact fracture J Gen Intern Med 18 1 17 22 10.1046/j.1525-1497.2003.20387.x 12534759 (Pubitemid 36114960)
28. MT Cuddihy SE Gabriel CS Crowson, et al. 2002 Osteoporosis intervention following distal forearm fractures: a missed opportunity? Arch Intern Med 162 4 421 426 10.1001/archinte.162.4.421 11863474
29. JT Harrington SB Broy AM Derosa AA Licata DA Shewmon 2002 Hip fracture patients are not treated for osteoporosis: a call to action Arthritis Rheum 47 6 651 654 10.1002/art.10787 12522840
30. SL Follin JN Black MT McDermott 2003 Lack of diagnosis and treatment of osteoporosis in men and women after hip fracture Pharmacotherapy 23 2 190 198 10.1592/phco.23.2.190.32090 12587808 (Pubitemid 36197460)
31. National Osteoporosis Foundation (2008) Physician's guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington
32. JA Kanis EV McCloskey H Johansson O Strom F Borgstrom A Oden 2008 Case finding for the management of osteoporosis with FRAX-assessment and intervention thresholds for the UK Osteoporos Int 19 10 1395 1408 10.1007/s00198-008-0712-1 1:STN:280:DC%2BD1crnvFelug%3D%3D 18751937
33. Kanis JA on behalf of the World Health Organization Scientific Group (2008) Assessment of osteoporosis at the primary health care level. University of Sheffield, UK, WHO Collaborating Center
34. PD Delmas ES Siris 2008 NICE recommendations for the prevention of osteoporotic fractures in postmenopausal women Bone 42 1 16 18 10.1016/j.bone.2007.10.020 18032125 (Pubitemid 350302014)
35. Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women: National Institute for Health and Clinical Excellence, 2007
36. Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women: National Institute for Health and Clinical Excellence, 2007
37. JR Curtis AO Westfall JJ Allison, et al. 2005 Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients Arthritis Rheum 52 8 2485 2494 10.1002/art.21194 16052570 (Pubitemid 41117436)
38. SK Shah GT Gecys 2006 Prednisone-induced osteoporosis: an overlooked and undertreated adverse effect J Am Osteopath Assoc 106 11 653 657 17192452
39. DH Solomon JN Katz JP Jacobs AM La Tourette J Coblyn 2002 Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice Arthritis Rheum 46 12 3136 3142 10.1002/art.10613 12483716 (Pubitemid 35453521)
40. JT Lin JM Lane 2003 Bisphosphonates J Am Acad Orthop Surg 11 1 1 4 12699366
41. Lauerman M, Issack P, Lane J. Bisphosphonates and Fracture Healing In Orthopaedic Fracture Patients. Canadian Orthopaedic Association Bulletin [February/March 2006; #72: http://www.coa-aco.org/coa-bulletin/issue-72.html. Accessed 19 March, 2009
42. Nordsletten L, Mesenbrink P, Magaziner J, et al. Association between timing of zoledronic acid infusion and hip fracture healing: HORIZON-RFT. American Academy of Orthopaedic Surgeons. Vol Las Vegas, NV2009
43. DH Solomon MC Hochberg H Mogun S Schneeweiss 2009 The relation between bisphosphonate use and non-union of fractures of the humerus in older adults Osteoporos Int 20 6 895 901 10.1007/s00198-008-0759-z 1:CAS:528: DC%2BD1MXls12ktrc%3D 18843515